These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7853858)

  • 21. Perspectives of Alzheimer's disease treatments.
    Davis JB; Bountra C; Richardson J
    Handb Clin Neurol; 2008; 89():273-90. PubMed ID: 18631752
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the trail of a cognitive enhancer for the treatment of schizophrenia.
    Stip E; Chouinard S; Boulay LJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice.
    Arendash GW; Cox AA; Mori T; Cracchiolo JR; Hensley KL; Roberts LJ
    Neuroreport; 2009 Aug; 20(12):1087-92. PubMed ID: 19543132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New strategies in the acute and chronic treatment of the patient with Alzheimer's dementia].
    Rocco PL
    Minerva Med; 1996 Apr; 87(4):171-7. PubMed ID: 8700341
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.
    Hanyu H; Sato T; Kiuchi A; Sakurai H; Iwamoto T
    J Am Geriatr Soc; 2009 Jan; 57(1):177-9. PubMed ID: 19170800
    [No Abstract]   [Full Text] [Related]  

  • 29. Medications for Alzheimer's disease. Benefits of currently approved drugs are limited, but research continues.
    Harv Ment Health Lett; 2011 Apr; 27(10):4-5. PubMed ID: 21786469
    [No Abstract]   [Full Text] [Related]  

  • 30. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of neurodegenerative disorders: Parkinson's disease and Alzheimer's disease.
    Pal PK; Netravathi M
    J Indian Med Assoc; 2005 Mar; 103(3):168-70, 172, 174-6. PubMed ID: 16173294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug may temporarily slow progression of mild cognitive impairment.
    Mayo Clin Womens Healthsource; 2005 Aug; 9(8):3. PubMed ID: 16015194
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of cholinesterase inhibitors in Alzheimer disease].
    Sampalmieri M; Troiani MP; Servi M
    Clin Ter; 1993 Dec; 143(6):549-52. PubMed ID: 8306579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 40. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
    Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
    Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.